ArticleAlimentary pharmacology & therapeuticsPublished
Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- Perelman School of Medicine, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Alimentary pharmacology & therapeutics
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Hepatocellular; Liver Neoplasms; Fatty Liver; Hypertension, Portal; Liver Cirrhosis; Metabolic Diseases; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Retrospective Studies; Glucagon-Like Peptide-1 Receptor Agonists; Hepatic Decompensation
- PubMed ID
- 38538967
- Added to directory
- Source checked